|
J Biol Chem, Vol. 274, Issue 26, 18243-18251, June 25, 1999
Mechanisms Involved in the Regulation of Free Fatty Acid Release
from Isolated Human Fat Cells by Acylation-stimulating Protein and
Insulin
Vanessa
Van Harmelen ,
Signy
Reynisdottir ,
Katherine
Cianflone§,
Eva
Degerman¶,
Johan
Hoffstedt ,
Klas
Nilsell ,
Allan
Sniderman§, and
Peter
Arner
From the Department of Medicine and
Research Center, Huddinge University Hospital, Karolinska Institute,
S-141 86 Huddinge, Sweden, the § Mike Rosenbloom
Laboratory for Cardiovascular Research, Royal Victoria Hospital, McGill
University, Montreal, Quebec H3A 1A1, Canada, the ¶ Department
of Cell and Molecular Biology, Section for Molecular Signalling, Lund
University, S-221 00 Lund, Sweden, and the Department of
Surgery, Huddinge University Hospital, Karolinska Institute,
S-141 86 Stockholm, Sweden
The effects of acylation-stimulating protein
(ASP) and insulin on free fatty acid (FFA) release from isolated human
fat cells and the signal transduction pathways to induce these effects
were studied. ASP and insulin inhibited basal and
norepinephrine-induced FFA release by stimulating fractional FFA
re-esterification (both to the same extent) and by inhibiting FFA
produced during lipolysis (ASP to a lesser extent than insulin).
Protein kinase C inhibition influenced none of the effects of ASP or
insulin. Phosphatidylinositol 3-kinase inhibition counteracted the
effects of insulin but not of ASP. Phosphodiesterase 3 (PDE3) activity
was stimulated by ASP and insulin, whereas PDE4 activity was slightly
increased by ASP only. Selective PDE3 inhibition reversed the effects
of both ASP and insulin on fractional FFA re-esterification and
lipolysis. Selective PDE4 inhibition slightly counteracted the ASP but
not the effect of insulin on fractional FFA re-esterification and did
not prevent the action of ASP or insulin on lipolysis. Thus, ASP and
insulin play a major role in regulating FFA release from fat cells as
follows: insulin by stimulating fractional FFA re-esterification and
inhibiting lipolysis and ASP mainly by stimulating fractional FFA
re-esterification. For both ASP and insulin these effects on FFA
release are mediated by PDE3, and for ASP PDE4 might also be involved.
The signaling pathway preceding PDE is not known for ASP but involves
phosphatidylinositol 3-kinase for insulin.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Bayol, B. H. Simbi, J. A. Bertrand, and N. C. Stickland
Offspring from mothers fed a 'junk food' diet in pregnancy and lactation exhibit exacerbated adiposity that is more pronounced in females
J. Physiol.,
July 1, 2008;
586(13):
3219 - 3230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Roy, S. Paglialunga, A. Fisette, P. Schrauwen, E. Moonen-Kornips, J. St-Onge, M. K. Hesselink, D. Richard, D. R. Joanisse, and K. Cianflone
Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet
Am J Physiol Endocrinol Metab,
June 1, 2008;
294(6):
E1051 - E1059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cui, S. Paglialunga, D. Kalant, H. Lu, C. Roy, M. Laplante, Y. Deshaies, and K. Cianflone
Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo
Am J Physiol Endocrinol Metab,
December 1, 2007;
293(6):
E1482 - E1491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Paglialunga, P. Schrauwen, C. Roy, E. Moonen-Kornips, H. Lu, M. K C Hesselink, Y. Deshaies, D. Richard, and K. Cianflone
Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice
J. Endocrinol.,
August 1, 2007;
194(2):
293 - 304.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Bauer, D. Nagaoka, B. Porterpan, K. Bigley, T. Umeda, and K. Otsuji
Postprandial Lipolytic Activities, Lipids, and Carbohydrate Metabolism Are Altered in Dogs Fed Diacylglycerol Meals Containing High- and Low-Glycemic-Index Starches
J. Nutr.,
July 1, 2006;
136(7):
1955S - 1957S.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Wernstedt, B. Olsson, M. Jernas, S. Paglialunga, L. M. S. Carlsson, U. Smith, K. Cianflone, K. Wallenius, and V. Wallenius
Increased Levels of Acylation-Stimulating Protein in Interleukin-6-Deficient (IL-6-/-) Mice
Endocrinology,
June 1, 2006;
147(6):
2690 - 2695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone
Targeting the signaling pathway of acylation stimulating protein
J. Lipid Res.,
March 1, 2006;
47(3):
643 - 652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Franckhauser, S. Munoz, I. Elias, T. Ferre, and F. Bosch
Adipose Overexpression of Phosphoenolpyruvate Carboxykinase Leads to High Susceptibility to Diet-Induced Insulin Resistance and Obesity
Diabetes,
February 1, 2006;
55(2):
273 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Wang, L. A. Reaves, and N. K. Edens
Ginseng Extract Inhibits Lipolysis in Rat Adipocytes In Vitro by Activating Phosphodiesterase 4
J. Nutr.,
February 1, 2006;
136(2):
337 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kalant, R. MacLaren, W. Cui, R. Samanta, P. N. Monk, S. A. Laporte, and K. Cianflone
C5L2 Is a Functional Receptor for Acylation-stimulating Protein
J. Biol. Chem.,
June 24, 2005;
280(25):
23936 - 23944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Engstrom, B. Hedblad, K.-F. Eriksson, L. Janzon, and F. Lindgarde
Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study
Diabetes,
February 1, 2005;
54(2):
570 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Enoksson, E. Hagstrom-Toft, J. Nordahl, K. Hultenby, N. Pettersson, B. Isaksson, J. Permert, R. Wibom, C. Holm, J. Bolinder, et al.
Marked Reutilization of Free Fatty Acids during Activated Lipolysis in Human Skeletal Muscle
J. Clin. Endocrinol. Metab.,
February 1, 2005;
90(2):
1189 - 1195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Jenkins, D. J. Mancuso, W. Yan, H. F. Sims, B. Gibson, and R. W. Gross
Identification, Cloning, Expression, and Purification of Three Novel Human Calcium-independent Phospholipase A2 Family Members Possessing Triacylglycerol Lipase and Acylglycerol Transacylase Activities
J. Biol. Chem.,
November 19, 2004;
279(47):
48968 - 48975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj and K. Cianflone
Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP
Am J Physiol Endocrinol Metab,
July 1, 2004;
287(1):
E150 - E159.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Persson, J. Boren, A.-K. L. Robertson, V. Wallenius, G. K. Hansson, and M. Pekna
Lack of Complement Factor C3, but Not Factor B, Increases Hyperlipidemia and Atherosclerosis in Apolipoprotein E-/- Low-Density Lipoprotein Receptor-/- Mice
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2004;
24(6):
1062 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Faraj, A. D. Sniderman, and K. Cianflone
ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes
J. Lipid Res.,
April 1, 2004;
45(4):
657 - 666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas
Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3
Am. J. Clinical Nutrition,
March 1, 2004;
79(3):
510 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xia, K. L. Stanhope, E. Digitale, O.-M. Simion, L. Chen, P. Havel, and K. Cianflone
Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice
J. Biol. Chem.,
February 6, 2004;
279(6):
4051 - 4057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cianflone, R. Zakarian, C. Couillard, B. Delplanque, J.-P. Despres, and A. Sniderman
Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance
J. Lipid Res.,
January 1, 2004;
45(1):
124 - 131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Linder, P. Arner, A. Flores-Morales, P. Tollet-Egnell, and G. Norstedt
Differentially expressed genes in visceral or subcutaneous adipose tissue of obese men and women
J. Lipid Res.,
January 1, 2004;
45(1):
148 - 154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tordjman, G. Chauvet, J. Quette, E. G. Beale, C. Forest, and B. Antoine
Thiazolidinediones Block Fatty Acid Release by Inducing Glyceroneogenesis in Fat Cells
J. Biol. Chem.,
May 23, 2003;
278(21):
18785 - 18790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Xia, A. D. Sniderman, and K. Cianflone
Acylation-stimulating Protein (ASP) Deficiency Induces Obesity Resistance and Increased Energy Expenditure in ob/ob Mice
J. Biol. Chem.,
November 22, 2002;
277(48):
45874 - 45879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev.,
April 1, 2002;
23(2):
201 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mei, L. S. Holst, T. R. Landstrom, C. Holm, D. Brindley, V. Manganiello, and E. Degerman
C2-Ceramide Influences the Expression and Insulin-Mediated Regulation of Cyclic Nucleotide Phosphodiesterase 3B and Lipolysis in 3T3-L1 Adipocytes
Diabetes,
March 1, 2002;
51(3):
631 - 637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ozata, C. Oktenli, M. Gulec, T. Ozgurtas, F. Bulucu, K. Caglar, N. Bingol, A. Vural, and I. C. Ozdemir
Increased Fasting Plasma Acylation-Stimulating Protein Concentrations in Nephrotic Syndrome
J. Clin. Endocrinol. Metab.,
February 1, 2002;
87(2):
853 - 858.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. ORourke, S. J. Yeaman, and P. R. Shepherd
Insulin and Leptin Acutely Regulate Cholesterol Ester Metabolism in Macrophages by Novel Signaling Pathways
Diabetes,
May 1, 2001;
50(5):
955 - 961.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. Imbeault, H. Vidal, A. Tremblay, N. Vega, A. Nadeau, J.-P. Després, and P. Mauriège
Age-Related Differences in Messenger Ribonucleic Acid Expression of Key Proteins Involved in Adipose Cell Differentiation and Metabolism
J. Clin. Endocrinol. Metab.,
February 1, 2001;
86(2):
828 - 833.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Kalant, S. Phélis, B. A. Fielding, K. N. Frayn, K. Cianflone, and A. D. Sniderman
Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women
J. Lipid Res.,
December 1, 2000;
41(12):
1963 - 1968.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
I. Murray, P. J. Havel, A. D. Sniderman, and K. Cianflone
Reduced Body Weight, Adipose Tissue, and Leptin Levels Despite Increased Energy Intake in Female Mice Lacking Acylation-Stimulating Protein
Endocrinology,
March 1, 2000;
141(3):
1041 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Murray, A. D. Sniderman, P. J. Havel, and K. Cianflone
Acylation Stimulating Protein (ASP) Deficiency Alters Postprandial and Adipose Tissue Metabolism in Male Mice
J. Biol. Chem.,
December 17, 1999;
274(51):
36219 - 36225.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|